INS and breast cancer: Markers of insulin resistance (IRm), such as high serum levels of insulin, insulin-like growth factor I (IGF-I), glucose, and the metabolic syndrome are associated with an increased risk of sporadic BC and may also affect BC prognosis [9,10,11,12,13].